Self-assembling peptide for local hemostasis during Endoscopic Treatment of Duodenum: A Observation Study
Not Applicable
Recruiting
- Conditions
- on-papillary superficial duodenal tumor
- Registration Number
- JPRN-UMIN000046432
- Lead Sponsor
- Kyoto Prefectural University of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
(1) In accordance with the "Guidelines for Gastrointestinal Endoscopy for Patients Taking Antithrombotic Drugs (2017 Supplement on Anticoagulants)", temporary discontinuation of antithrombotic medication is not possible and endoscopic treatment cannot be performed (discontinuation of medication is not mandatory if endoscopic treatment is possible). (2) Patients with infections that require systemic treatment (3) Pregnant or lactating women (4) Patients for whom follow-up after 4 weeks is not possible (5) Patients who are judged inappropriate by the investigator.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method